The Insider: Meet the CEOs Webcast Replay

We were joined by the CEOs of exciting ASX-listed businesses, who gave valuable insight to their industries and companies future prospects.

  • (ASX: TZL) TZ Limited – Mario Vecchio, CEO
  • (ASX: WNX) Wellnex Life – George Karafotias, CEO
  • (ASX: MVF) Monash IVF Group – Michael Knaap

Recorded on 27 October 2021 at 12pm (AEDT).

Join the next The Insider: Meet the CEOs webcast

Speak to the Reach Markets team


Mario Vecchio

Chief Executive Officer - TZ Limited (ASX: TZL)

TZ Limited is a tech innovator that has been at the forefront of Internet of Things research and development since 2004, and is uniquely positioned as a category leader and disruptor. The company solves real-world problems, by engineering software solutions centred around access and control of physical spaces. TZ has demonstrated success with an expanding US pipeline and an A-list client base, including companies such as Apple, Microsoft, Google, Amazon and Westpac. The company is targeting significant recurring revenue growth with a shift to multi-term software service agreements and enabling third-party access through their SaaS platform.

George Karafotias

Chief Executive Officer - Wellnex Life (ASX: WNX)

Wellnex Life is a brand developer and distributor of health and wellness products in the growing $5.6 billion Australian health and wellness market. Partnering with some of Australia’s largest retailers, including Chemist Warehouse, Woolworths and Coles, the company is poised to be a disruptor in the industry. Wellnex has grown its revenue from $6.7 million to $18.3 million in three years, and is forecast to exceed $21 million in revenue in FY22. A large portfolio, first-to-market strategy and an established retail distribution network provide an attractive business model for growth and profitability.

Michael Knaap

Chief Executive Officer - Monash IVF Group (ASX: MVF)

Monash IVF Group is the pioneer of IVF and a global leader in assisted reproductive services, genetic testing and ultrasound services. The company was the first to achieve successful IVF and has since been a driving force in the development of assisted reproductive technologies and tertiary level prenatal diagnostics. Monash IVF Group currently has a market share of 21% and operates more than 40 fertility and ultrasound clinics across Australia. Showing a 61.5% increase in net profits and 26.3% revenue growth in FY21, the company is poised to grow considerably with the increasing demand for fertility services.

latest other webcasts

Pitt Street Research on Prescient Therapeutics

Credit Clear Limited (ASX: CCR) Investor Briefing – 20 September

Alto Metals Ltd (ASX: AME) Investor Briefing – 20 September

Speak to the Reach Markets team

What is a 708 investor?

By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.